Venous thromboembolic disease genetics: from variants to function
Mary Underwood1, Christopher Bidlack2, Karl C Desch3
1Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Recent studies reveal new genetic risk factors for venous thromboembolic disease (VTE), a serious vascular condition. Understanding these heritable factors improves VTE risk prediction and identifies new therapeutic targets.
Area of Science:
- Genetics and Vascular Biology
- Thrombosis Research
Background:
- Venous thromboembolic disease (VTE), encompassing deep vein thrombosis and pulmonary embolism, is a significant cause of morbidity and mortality.
- Heritable factors play a crucial role in an individual's susceptibility to VTE.
- Current understanding of genetic contributions to VTE is continually evolving.
Purpose of the Study:
- To review recent advancements in identifying genetic risk variants for VTE.
- To emphasize the importance of functional characterization of these genetic variants.
- To explore how genetic insights can improve VTE risk prediction and understanding of its biological mechanisms.
Main Methods:
- Review of recent genome-wide association studies (GWAS) and genetic discovery efforts.
- Analysis of functional studies characterizing the impact of identified genetic variants.
- Integration of findings to understand gene function beyond the traditional coagulation system.
Main Results:
- Discovery of novel genetic variants associated with VTE risk.
- Demonstration of the functional significance of these variants in thrombus formation.
- Identification of genes involved in VTE pathogenesis both within and outside the canonical coagulation cascade.
Conclusions:
- Genetic variations significantly influence VTE risk.
- Functional characterization of genetic variants is essential for understanding VTE pathophysiology.
- Advancements in human genome sequencing and functional genetic screens will accelerate VTE research and improve risk prediction.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Genetic Variation
Genes exist in different versions called alleles,...
